• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Lazard Inc. filed SEC Form 8-K: Regulation FD Disclosure

    9/10/25 8:00:24 AM ET
    $LAZ
    Investment Managers
    Finance
    Get the next $LAZ alert in real time by email
    laz-20250910
    0001311370FALSE00013113702025-09-102025-09-10

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    ________________________________________________
    FORM 8-K
    ________________________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): September 10, 2025
    ________________________________________________
    Lazard, Inc.
    (Exact name of registrant as specified in its charter)
    ________________________________________________
    Delaware001-3249298-0437848
    (State or Other Jurisdiction
    of Incorporation)
    (Commission File Number)(IRS Employer
    Identification No.)
    30 Rockefeller Plaza
    New York, New York
    10112
    (Address of Principal Executive Offices)(Zip Code)
    Registrant’s Telephone Number, Including Area Code: 212-632-6000
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
    ________________________________________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading
    Symbol(s)
    Name of each exchange on which registered
    Common Stock, par value $0.01 per shareLAZNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
    Emerging growth company o
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
    Item 7.01    Regulation FD Disclosure.

    On September 10, 2025, Lazard, Inc. (the “Company”) posted to its website a letter related to, among other things, an update to the Company’s vision and long-term growth strategy for Lazard 2030.

    The information in this Current Report on Form 8-K under Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.

    Cautionary Note Regarding Forward-Looking Statements:

    This Current Report on Form 8-K and the letter referenced herein contain forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “target,” “goal,” “pipeline,” or “continue,” and the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include statements about our vision and long-term growth strategy for Lazard 2030 and projections of our future financial and operational performance based on our growth strategies, business plans and initiatives, including those related to artificial intelligence, and anticipated trends in our business. These forward-looking statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by these forward-looking statements.

    These factors include, but are not limited to, those discussed in our Annual Report on Form 10-K under Item 1A “Risk Factors,” and also discussed from time to time in our reports on Forms 10-Q and 8-K, including the following:

    •adverse general economic conditions or adverse conditions in global or regional financial markets;
    •changes in international trade policies and practices, including the implementation of tariffs, proposed further tariffs, and responses from other jurisdictions, and the economic impacts, volatility and uncertainty resulting therefrom;
    •a decline in our revenues, for example due to a decline in overall mergers and acquisitions (“M&A”) activity, our share of the M&A market or our assets under management;
    •losses caused by financial or other problems experienced by third parties;
    •losses due to unidentified or unanticipated risks;
    •a lack of liquidity, i.e., ready access to funds, for use in our businesses;
    •competitive pressure on our businesses and on our ability to retain and attract employees at current compensation levels;
    •changes in relevant tax laws, regulations or treaties or an adverse interpretation of those items; and
    •potential impact of investments in our technology infrastructure and data science capabilities, including our objectives with respect to advancing technologies such as artificial intelligence.

    These risks and uncertainties are not exhaustive. Other sections of our reports on Forms 10-K and 10-Q describe additional factors that could adversely affect our business and financial performance. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

    Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. We are under no duty to update any of these forward-looking statements after the date of this release to conform our prior statements to actual results or revised expectations and we do not intend to do so.



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
    LAZARD, INC.
    (Registrant)
    By:/s/ Shari L. Soloway
    Name:Shari L. Soloway
    Title:Corporate Secretary
    Dated: September 10, 2025

    Get the next $LAZ alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LAZ

    DatePrice TargetRatingAnalyst
    8/25/2025$65.00Mkt Perform → Outperform
    Keefe Bruyette
    4/7/2025$56.00 → $33.00Equal-Weight → Underweight
    Morgan Stanley
    1/3/2025Outperform → Peer Perform
    Wolfe Research
    12/20/2024$65.00 → $57.00Outperform → Mkt Perform
    Keefe Bruyette
    12/9/2024$60.00 → $63.00Overweight → Equal-Weight
    Morgan Stanley
    9/12/2024$51.00Equal Weight
    Wells Fargo
    1/29/2024$51.00Outperform
    Keefe Bruyette
    1/3/2024$42.00Peer Perform → Outperform
    Wolfe Research
    More analyst ratings

    $LAZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Shevelenko Dmitry

    4 - Lazard, Inc. (0001311370) (Issuer)

    9/18/25 4:30:18 PM ET
    $LAZ
    Investment Managers
    Finance

    CEO & Chairman Orszag Peter Richard converted options into 64,949 shares, returned $1,083,171 worth of shares to the company (19,485 units at $55.59) and sold $1,756,573 worth of shares (32,475 units at $54.09), increasing direct ownership by 8% to 183,274 units (SEC Form 4)

    4 - Lazard, Inc. (0001311370) (Issuer)

    9/17/25 8:06:50 PM ET
    $LAZ
    Investment Managers
    Finance

    CEO of Asset Management Russo Evan L gifted 15,000 shares and sold $4,240,260 worth of shares (75,000 units at $56.54), decreasing direct ownership by 28% to 227,915 units (SEC Form 4)

    4 - Lazard, Inc. (0001311370) (Issuer)

    9/11/25 7:27:29 PM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lazard Welcomes Cyrille Cotte as Managing Director and Head of Insurance for European Financial Institutions

    Lazard, Inc. (NYSE:LAZ) today announced the appointment of Cyrille Cotte as Managing Director and Head of Insurance for its European Financial Institutions Group (FIG), based in London and working across Europe with regional Co-Heads of Financial Services Coverage Nick Millar and Corso Bavagnoli. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930678445/en/Cyrille Cotte Cyrille joins Lazard from Evercore, where he was a Partner and Senior Managing Director in the European Financial Institutions Group. Over his career, he has focused on advising a broad range of insurers and other financial services firms on mergers, acquisitio

    10/1/25 2:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in August

    Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on October 22, 2025, to shareholders of record on October 10, 2025. The ex-dividend date is October 10, 2025. The Fund will pay a previously declared distribution today, September 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment income,

    9/22/25 4:05:00 PM ET
    $LAZ
    $LGI
    Investment Managers
    Finance

    Lazard Hires Geoffrey Porges to Healthcare Advisory Group

    Lazard announced today that Dr. Geoffrey Porges has joined the firm as Managing Director in the Healthcare Advisory Group, advising on transactions across diversified biopharmaceuticals. "We are thrilled to welcome Geoffrey to Lazard," said David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare. "His deep understanding of the biopharmaceutical industry's strategic and financial landscape, coupled with his ability to help companies translate scientific innovation into actionable business strategies, will empower our clients to strengthen their competitive positions, capitalize on growth opportunities, and build resilient companies in a challenging geopolitical an

    9/18/25 7:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lazard upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Lazard from Mkt Perform to Outperform and set a new price target of $65.00

    8/25/25 8:08:17 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Lazard from Equal-Weight to Underweight and set a new price target of $33.00 from $56.00 previously

    4/7/25 7:56:16 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard downgraded by Wolfe Research

    Wolfe Research downgraded Lazard from Outperform to Peer Perform

    1/3/25 7:37:05 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    SEC Filings

    View All

    SEC Form 144 filed by Lazard Inc.

    144 - Lazard, Inc. (0001311370) (Subject)

    9/10/25 4:41:06 PM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Lazard, Inc. (0001311370) (Filer)

    9/10/25 8:00:24 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - Lazard, Inc. (0001311370) (Filer)

    9/8/25 8:01:09 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Leadership Updates

    Live Leadership Updates

    View All

    Lazard Welcomes Cyrille Cotte as Managing Director and Head of Insurance for European Financial Institutions

    Lazard, Inc. (NYSE:LAZ) today announced the appointment of Cyrille Cotte as Managing Director and Head of Insurance for its European Financial Institutions Group (FIG), based in London and working across Europe with regional Co-Heads of Financial Services Coverage Nick Millar and Corso Bavagnoli. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930678445/en/Cyrille Cotte Cyrille joins Lazard from Evercore, where he was a Partner and Senior Managing Director in the European Financial Institutions Group. Over his career, he has focused on advising a broad range of insurers and other financial services firms on mergers, acquisitio

    10/1/25 2:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Hires Geoffrey Porges to Healthcare Advisory Group

    Lazard announced today that Dr. Geoffrey Porges has joined the firm as Managing Director in the Healthcare Advisory Group, advising on transactions across diversified biopharmaceuticals. "We are thrilled to welcome Geoffrey to Lazard," said David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare. "His deep understanding of the biopharmaceutical industry's strategic and financial landscape, coupled with his ability to help companies translate scientific innovation into actionable business strategies, will empower our clients to strengthen their competitive positions, capitalize on growth opportunities, and build resilient companies in a challenging geopolitical an

    9/18/25 7:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Christopher Hogbin Joins Lazard Asset Management as Chief Executive Officer

    Succeeds Evan Russo who transitions into advisory role following two decades of leadership at the firm Lazard, Inc. (NYSE:LAZ) today announced Christopher Hogbin has been appointed CEO of Lazard Asset Management, effective December 2025. Mr. Hogbin has 30 years of professional experience, including 20 years at AllianceBernstein where he most recently served as Global Head of Investments and a member of its Executive Leadership Team. An accomplished global business and investment leader, Mr. Hogbin played a pivotal role in expanding and diversifying AllianceBernstein's investment capabilities across public and private markets, elevating its research function, and delivering exceptional out

    9/8/25 8:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Financials

    Live finance-specific insights

    View All

    Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in August

    Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on October 22, 2025, to shareholders of record on October 10, 2025. The ex-dividend date is October 10, 2025. The Fund will pay a previously declared distribution today, September 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment income,

    9/22/25 4:05:00 PM ET
    $LAZ
    $LGI
    Investment Managers
    Finance

    Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in July

    Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on September 22, 2025, to shareholders of record on September 11, 2025. The ex-dividend date is September 11, 2025. The Fund will pay a previously declared distribution today, August 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment incom

    8/22/25 4:05:00 PM ET
    $LAZ
    $LGI
    Investment Managers
    Finance

    Lazard Reports Second Quarter and First Half 2025 Results

    Financial Advisory reported record adjusted net revenue for the second quarter up 20% year over year and driven by robust activity in Europe Asset Management reported positive net flows in the second quarter and AUM of $248 billion as of June 30, 2025 Financial Advisory hired 14 Managing Directors year to date, underscoring success in attracting world-class talent to support long-term growth Lazard, Inc. (NYSE:LAZ) today reported net revenue of $796 million and adjusted net revenue1 of $770 million for the quarter ended June 30, 2025. For the first half of 2025, Lazard reported net revenue of $1,444 million and adjusted net revenue1 of $1,413 million. On both a U.S. GAAP and

    7/24/25 6:30:00 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Lazard Inc.

    SC 13G - Lazard, Inc. (0001311370) (Subject)

    11/8/24 2:17:07 PM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Lazard LTD. Lazard LTD. (Amendment)

    SC 13G/A - Lazard, Inc. (0001311370) (Subject)

    2/14/24 9:41:26 AM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Lazard LTD. Lazard LTD. (Amendment)

    SC 13G/A - Lazard, Inc. (0001311370) (Subject)

    2/9/24 9:16:05 AM ET
    $LAZ
    Investment Managers
    Finance